Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Infectious Diseases
Authors: Ronald H Behrens, Jakob P Cramer, Tomas Jelinek, Hilary Shaw, Frank von Sonnenburg, Darren Wilbraham, Thomas Weinke, David J Bell, Edwin Asturias, Hermann L Enkerlin Pauwells, Roberto Maxwell, Mercedes Paredes-Paredes, Gregory M Glenn, Shailesh Dewasthaly, Donald M Stablein, Zhi-Dong Jiang, Herbert L DuPont
Institutions: London School of Hygiene & Tropical Medicine, Hospital for Tropical Diseases, Bernhard Nocht Institute for Tropical Medicine, Ludwig-Maximilians-Universität München, Guy's Hospital, BioKinetic Europe (United Kingdom), University of Colorado Denver, The University of Texas Health Science Center at Houston, Novavax (United States), Intercell (Austria), Emmes (United States)
Language: English
Topic: Travel-related health issues
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2159101101